This is the banner text
About
Our firm
Our Team
Strategy
Industry focus
Value creation
Responsibility
portfolio
news
contact
Login
Investment
Revance
Visit site
Revance is a marketer and manufacturer of leading skincare products sold in both the OTC and aesthetic channels.
Investment year:
2017
Status:
Partial exit (HCP I), Private (HPP I & HEP III)
Website:
www.revance.com
See next investment.
Go now
Tebra
A cloud-based, clinical and business management platform